About Rigenerand
Rigenerand is a company based in Medolla (Italy) founded in 2009 was acquired by Evotec in May 2022.. Rigenerand offers products and services including cGMP products and 3D culture biomedical devices.
- Headquarter Medolla, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rigenerand Srl
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rigenerand
Rigenerand offers a comprehensive portfolio of products and services, including cGMP products and 3D culture biomedical devices. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
cGMP products are developed and produced for cell and gene therapy applications, focusing on manufacturing standards that are applied in therapeutic contexts.
3D culture biomedical devices are created for diagnostic and therapeutical uses, where they are employed to support cell-based innovations in medical fields.
Funding Insights of Rigenerand
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $436,035
-
First Round
First Round
(01 Nov 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Grant - Rigenerand | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rigenerand
Rigenerand has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Evotec and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Drug discovery and development services are provided to biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rigenerand
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rigenerand
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rigenerand Comparisons
Competitors of Rigenerand
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Rigenerand
When was Rigenerand founded?
Rigenerand was founded in 2009 and raised its 1st funding round 11 years after it was founded.
Where is Rigenerand located?
Rigenerand is headquartered in Medolla, Italy. It is registered at Medolla, Emilia-romagna, Italy.
Who is the current CEO of Rigenerand?
Giorgio Mari is the current CEO of Rigenerand.
What does Rigenerand do?
Rigenerand was founded in 2009 and is based in Medolla, Italy. Operations are focused on the biotechnology sector, where cGMP-compliant products for cell and gene therapy are developed and manufactured. Services include production processes that meet regulatory standards for therapeutic applications. The company supports advancements in regenerative medicine through its specialized facilities and expertise in compliant bioprocessing.
What products or services does Rigenerand offer?
Rigenerand offers cGMP products and 3D culture biomedical devices.
Who are Rigenerand's investors?
Rigenerand has 2 investors. Key investors include Evotec, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.